3D Systems reported a decrease in revenue by 9% year-over-year, primarily due to macro weakness in printer sales, while healthcare solutions revenue increased by 5%. The company experienced a net loss of $178.6 million, including a $143.7 million impairment charge. They are updating guidance for the remainder of FY'24 to include expected full-year revenues within the range of $440 million - $450 million.
Revenue decreased 9% year-over-year to $112.9 million due to macro weakness in printer sales, but consumables sales grew by approximately 10%.
Healthcare Solutions revenue grew 5% year-over-year to $55.1 million, driven by Dental and Personalized Healthcare solutions.
Customer interest in 3D printing applications continued to increase, with revenues in the Application Innovation Group (AIG) growing over 26% year-to-date.
Q3'24 net loss was $178.6 million, or $1.35 diluted loss per share, including $143.7 million associated with asset impairment, with a non-GAAP diluted loss per share of $0.12.
3D Systems updated its full-year 2024 revenue guidance to a range of $440 million to $450 million, expects Non-GAAP operating expenses to be less than $60 million for Q4'24, and anticipates sequential improvement in Adjusted EBITDA.